![](/img/cover-not-exists.png)
P558 Antibodies against infliximab are associated with increased risk of anti-adalimumab antibody development in patients with inflammatory bowel disease
Frederiksen, M.T., Ainsworth, M.A., Brynskov, J., Thomsen, O.Ø., Bendtzen, K., Steenholdt, C.Volume:
8
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1016/S1873-9946(14)60678-4
Date:
February, 2014
File:
PDF, 55 KB
english, 2014